Nguyen Giang Thu Lan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nguyen Giang Thu Lan has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Channarong Rodkhum
Center of Excellence in Fish Infectious Diseases (CE FID), Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand
3 shared publications Nguyen Tien Vinh
3 shared publications- Saengchan Senapin
Fish Health Platform, Center of Excellence for Shrimp Molecular Biology and Biotechnology (Centex Shrimp), Faculty of Science, Mahidol University, Bangkok, Thailand
3 shared publications Andrew P. Shinn
INVE Aquaculture Nonthaburi Thailand
2 shared publicationsHa Thanh Dong
2 shared publications- Ha Thanh Dong
Aquaculture and Aquatic Resources Management, Faculty of Food, Agriculture and Natural Resources, Asian Institute of Technology, Pathum Thani, Thailand
2 shared publications
Latest Publications
- Open Access
- 6 August 2025
- Published by Elsevier in Comparative Immunology Reports
- Vol. 9
Non-invasive vaccination enhances immune response and protects Asian seabass (Lates calcarifer) against Vibrio vulnificus infection
- 6 August 2025
- Published by Elsevier in Comparative Immunology Reports
- Vol. 9
Open AccessNon-invasive vaccination enhances immune response and protects Asian seabass (Lates calcarifer) against Vibrio vulnificus infection
- 26 May 2024
- Published by Wiley in Journal of Fish Diseases
- Vol. 47 (8) , e13964
Review of current perspectives and future outlook on bacterial disease prevention through vaccination in Asian seabass (Lates calcarifer)
Asian seabass, Lates calcarifer, is an important aquatic species in mariculture. Intensive farming of this species has faced episodes of bacterial diseases, including those due to vibriosis, scale drop, and muscle necrosis disease, big belly disease, photobacteriosis, columnaris, streptococcosis, aeromoniasis, and tenacibaculosis. Vaccination is one of the most efficient, non‐antibiotic, and eco‐friendly strategies for protecting fish against bacterial diseases, contributing to aquaculture expansion and ensuring food security. As of now, although numerous vaccines have undergone laboratory research, only one commercially available inactivated vaccine, suitable for both immersion and injection administration, is accessible for preventing Streptococcus iniae. Several key challenges in developing vaccines for Asian seabass must be addressed, such as the current limited understanding of immunological responses to vaccines, the costs associated with vaccine production, forms, and routes of vaccine application, and how to increase the adoption of vaccines by farmers. The future of vaccine development for the Asian seabass industry, therefore, is discussed with these key critical issues in mind. The focus is on improving our understanding of Asian seabass immunity, including maternal immunity, immunocompetence, and immune responses post‐vaccination, as well as developing tools to assess vaccine effectiveness. The need for an alignment of fish vaccines with state‐of‐the‐art vaccine technologies employed in human and terrestrial animal healthcare is also discussed. This review also discusses the necessity of providing locally‐produced autogenous vaccines, especially for immersion and oral vaccines, to benefit small‐scale fish farmers, and the potential benefits that might be extended through changes to current husbandry practices such as the vaccination of broodstock and earlier life stages of their off‐spring.
- 26 May 2024
- Published by Wiley in Journal of Fish Diseases
- Vol. 47 (8) , e13964
Review of current perspectives and future outlook on bacterial disease prevention through vaccination in Asian seabass (Lates calcarifer)
Asian seabass, Lates calcarifer, is an important aquatic species in mariculture. Intensive farming of this species has faced episodes of bacterial diseases, including those due to vibriosis, scale drop, and muscle necrosis disease, big belly disease, photobacteriosis, columnaris, streptococcosis, aeromoniasis, and tenacibaculosis. Vaccination is one of the most efficient, non‐antibiotic, and eco‐friendly strategies for protecting fish against bacterial diseases, contributing to aquaculture expansion and ensuring food security. As of now, although numerous vaccines have undergone laboratory research, only one commercially available inactivated vaccine, suitable for both immersion and injection administration, is accessible for preventing Streptococcus iniae. Several key challenges in developing vaccines for Asian seabass must be addressed, such as the current limited understanding of immunological responses to vaccines, the costs associated with vaccine production, forms, and routes of vaccine application, and how to increase the adoption of vaccines by farmers. The future of vaccine development for the Asian seabass industry, therefore, is discussed with these key critical issues in mind. The focus is on improving our understanding of Asian seabass immunity, including maternal immunity, immunocompetence, and immune responses post‐vaccination, as well as developing tools to assess vaccine effectiveness. The need for an alignment of fish vaccines with state‐of‐the‐art vaccine technologies employed in human and terrestrial animal healthcare is also discussed. This review also discusses the necessity of providing locally‐produced autogenous vaccines, especially for immersion and oral vaccines, to benefit small‐scale fish farmers, and the potential benefits that might be extended through changes to current husbandry practices such as the vaccination of broodstock and earlier life stages of their off‐spring.
- 10 April 2024
- Published by Elsevier in Fish & Shellfish Immunology
- Vol. 149, 109557
A novel vaccination strategy against Vibrio harveyi infection in Asian seabass (Lates calcarifer) with the aid of oxygen nanobubbles and chitosan
- 10 April 2024
- Published by Elsevier in Fish & Shellfish Immunology
- Vol. 149, 109557
A novel vaccination strategy against Vibrio harveyi infection in Asian seabass (Lates calcarifer) with the aid of oxygen nanobubbles and chitosan